PsyPost
No Result
View All Result
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Cannabinoids remove plaque-forming Alzheimer’s proteins from brain cells

by Salk Institute
June 29, 2016
in Psychopharmacology
Photo credit: National Institute on Aging

Photo credit: National Institute on Aging

Share on FacebookShare on Twitter

Salk Institute scientists have found preliminary evidence that tetrahydrocannabinol (THC) and other compounds found in marijuana can promote the cellular removal of amyloid beta, a toxic protein associated with Alzheimer’s disease.

While these exploratory studies were conducted in neurons grown in the laboratory, they may offer insight into the role of inflammation in Alzheimer’s disease and could provide clues to developing novel therapeutics for the disorder.

“Although other studies have offered evidence that cannabinoids might be neuroprotective against the symptoms of Alzheimer’s, we believe our study is the first to demonstrate that cannabinoids affect both inflammation and amyloid beta accumulation in nerve cells,” says Salk Professor David Schubert, the senior author of the paper.

Alzheimer’s disease is a progressive brain disorder that leads to memory loss and can seriously impair a person’s ability to carry out daily tasks. It affects more than five million Americans according to the National Institutes of Health, and is a leading cause of death. It is also the most common cause of dementia and its incidence is expected to triple during the next 50 years.

It has long been known that amyloid beta accumulates within the nerve cells of the aging brain well before the appearance of Alzheimer’s disease symptoms and plaques. Amyloid beta is a major component of the plaque deposits that are a hallmark of the disease. But the precise role of amyloid beta and the plaques it forms in the disease process remains unclear.

In a manuscript published in June 2016’s Aging and Mechanisms of Disease, Salk team studied nerve cells altered to produce high levels of amyloid beta to mimic aspects of Alzheimer’s disease.

The researchers found that high levels of amyloid beta were associated with cellular inflammation and higher rates of neuron death. They demonstrated that exposing the cells to THC reduced amyloid beta protein levels and eliminated the inflammatory response from the nerve cells caused by the protein, thereby allowing the nerve cells to survive.

“Inflammation within the brain is a major component of the damage associated with Alzheimer’s disease, but it has always been assumed that this response was coming from immune-like cells in the brain, not the nerve cells themselves,” says Antonio Currais, a postdoctoral researcher in Schubert’s laboratory and first author of the paper. “When we were able to identify the molecular basis of the inflammatory response to amyloid beta, it became clear that THC-like compounds that the nerve cells make themselves may be involved in protecting the cells from dying.”

Brain cells have switches known as receptors that can be activated by endocannabinoids, a class of lipid molecules made by the body that are used for intercellular signaling in the brain. The psychoactive effects of marijuana are caused by THC, a molecule similar in activity to endocannabinoids that can activate the same receptors. Physical activity results in the production of endocannabinoids and some studies have shown that exercise may slow the progression of Alzheimer’s disease.

Schubert emphasized that his team’s findings were conducted in exploratory laboratory models, and that the use of THC-like compounds as a therapy would need to be tested in clinical trials.

In separate but related research, his lab found an Alzheimer’s drug candidate called J147 that also removes amyloid beta from nerve cells and reduces the inflammatory response in both nerve cells and the brain. It was the study of J147 that led the scientists to discover that endocannabinoids are involved in the removal of amyloid beta and the reduction of inflammation.

ShareTweetSendScanShareSharePinSend

Get all the latest updates on new psychology research with the free PsyPost app.
 


NEWSLETTER SIGN-UP

STAY CONNECTED

TRENDING

Body dysmorphic disorder linked to deficits in cognitive flexibility and visuospatial skills

Tattoos and piercings are more common among those who experienced childhood abuse and neglect

Scientists discover an illusion that is strong enough to trick our reflexes

Shyness linked to reduced behavioral mimicry during conversation via heightened self-focused attention

The balance of power among couples appears to influence female sexual desire via relationship satisfaction

Study indicates that thin influencers do not motivate healthy food choices among tweens

RECENT

New psychology research indicates that partisan biases can promote false memories

Gender-neutral text perceived as less comprehensible than gendered text in Polish, study finds

Exercise enhances our enjoyment of music, possibly through increased arousal

Study indicates that thin influencers do not motivate healthy food choices among tweens

The balance of power among couples appears to influence female sexual desire via relationship satisfaction

  • Cognitive Science
  • COVID-19
  • Mental Health
  • Social Psychology
  • Drug Research
  • Conspiracy Theories
  • Meditation
  • Psychology of Religion
  • Aviation Psychology and Human Factors
  • Relationships and Sexual Health
Powered by

About

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Contact us
  • Privacy policy

No Result
View All Result
  • About
    • Newsletter signup form
  • Cart
  • Checkout
  • Contact
  • Contact us
  • My account
  • Privacy policy
  • Psychology news
  • PsyPost app privacy policy
  • Shop
  • SmartMag Home

This website uses cookies. By continuing to use this website you are giving consent to cookies being used.